Reporting from the Texas Department of State Health Services shows that COVID-19 hospitalizations have climbed recently in Texas. As we wait for developments on therapeutics and vaccines, I hope each of you will continue to wash your hands, wear a mask, and practice social distancing. Everyone has made sacrifices over the past 7 months, and I am thankful that Texans have rallied during these challenging times. I remain committed to ensuring that every resource at the federal level is directed toward public health and economic recovery.
Number of COVID-19 Hospitalizations in Texas from April 4-October 26. On October 26, 5,278 Texans were hospitalized with COVID-19. At the peak on July 22, there were 10,893 hospitalized patients.
National Updates: AstraZenecaresumed Phase 3 trials for its COVID-19 vaccine candidate following a thorough safety data review by the Food and Drug Administration. Johnson & Johnsonis preparing to resume its Phase 3 trial after concluding that the vaccine did not cause a serious medical event in one participant.
The Center of Disease Control(CDC) posted guidance to help voters and election officials reduce the risk of COVID-19 transmission while at polling locations.
The Food and Drug Administration shared a video of Commissioner Steve Hahn explaining the process of developing a vaccine.
Eli Lilly and Company is ending its Phase 3 clinical trial of Bamlanivimab, a monoclonal antibody, in hospitalized COVID-19 patients, as data suggests the drug’s limited efficacy for late stages of the virus.
Texas Updates The Texas Department of State Health Services(DSHS) added two additional Trauma Service Areas to the list of high COVID-19 hospitalizations which must postpone voluntary surgeries and procedures that would limit hospital capacity.
The Texas Health and Human Services Commission(HHSC) has extended most Medicaid and Children’s Health Program flexibilities through November 30th.